Coat colour changes associated with cabergoline administration in bitches.

Cabergoline or bromocriptine were administered orally to 60 bitches at doses of 5 microg/kg and 15 microg/kg daily, respectively, for two to 45 days for the treatment of pseudopregnancy or for oestrus induction. Seven of the dogs which received cabergoline for more than 14 days developed coat colour changes from the second week of administration to the next coat shedding. Of these, fawn-coloured bitches developed a yellowish coat colour while Argentine boar hounds became black spotted, mainly on their extremities. In previous untreated oestrous periods, these bitches had shown no coat colour changes. It is concluded that a colour shift in certain haircoats of particular breeds could be mediated through the inhibition of the secretion of melanocyte-stimulating hormone by the administration of the dopaminergic agonist cabergoline for more than two weeks. Transient coat colour changes should be considered a possible side effect when planning long-term treatment with dopaminergic agonists in dogs.

[1]  C. Gobello,et al.  Use of cabergoline to treat primary and secondary anestrus in dogs. , 2002, Journal of the American Veterinary Medical Association.

[2]  R. L. de la Sota,et al.  Use of prostaglandins and bromocriptine mesylate for pregnancy termination in bitches. , 2002, Journal of the American Veterinary Medical Association.

[3]  R. Goya,et al.  Study of the change of prolactin and progesterone during dopaminergic agonist treatments in pseudopregnant bitches. , 2001, Animal reproduction science.

[4]  S. Greven,et al.  Pulsatile secretion of α-MSH and the differential effects of dexamethasone and haloperidol on the secretion of α-MSH and ACTH in dogs , 1997 .

[5]  V. Hruby,et al.  Coat color darkening in a dog in response to a potent melanotropic peptide. , 1994, American journal of veterinary research.

[6]  J. Mol,et al.  Effects of bromocriptine on corticotrophin, melanotrophin and corticosteroid secretion in dogs with pituitary-dependent hyperadrenocorticism. , 1988, The Journal of endocrinology.

[7]  R. Kemppainen,et al.  In vivo evidence for dopaminergic regulation of the canine pituitary intermediate lobe. , 1986, Acta endocrinologica.

[8]  S. Shuster,et al.  α-MSH and coat color changes in the mouse , 1984, Peptides.

[9]  C. G. Gómez Dumm,et al.  Alteration of the Agouti mouse coat color pattern by bromoergocryptine. Possible involvement of MSH. , 1979, Neuroendocrinology.

[10]  F. Tilders,et al.  Effects of hypothalamic lesions and drugs interfering with dopaminergic transmission on pituitary MSH content of rats. , 1978, Neuroendocrinology.

[11]  A. Howe The mammalian pars intermedia: a review of its structure and function. , 1973, The Journal of endocrinology.

[12]  C. C. Rust HORMONAL CONTROL OF PELAGE CYCLES IN THE SHORT TAILED WEASEL (MUSTELA ERMINEA BANGSI). , 1965, General and comparative endocrinology.